Pathways' Pick of the Week: Africa Centralizes Medtech Regulations

article image
ARTICLE SUMMARY:

The African Medicines Agency launches. Excerpted from Pathways’ Picks May 28: Global Picks, FDA Guidance Docs, MDUFA Support, and More.

Africa is on the cusp of fully launching its continent-wide agency for centralizing and harmonizing oversight of drugs, vaccines, and medical devices. Even as the top-down structure of the African Medicines Agency (AMA) is still being put into place, there is already an infrastructure established to initiate medtech regulatory efforts. This foundation helped keep track of availability and performance of IVDs for COVID-19, and now it is stepping up to serve a more direct premarket review function for the continent in response to the Mpox (or monkeypox) outbreak in a growing number of African countries. (For more on AMA and medtech harmonization efforts in Africa, see in Market Pathways, Charting a Continent’s Course: Africa’s Push Toward Harmonized Medical Device Regulation.”)

Continue reading Pathways’ Picks here.
×



Articles from David Filmore:

Regulatory & Reimbursement

Quality Info in FDA Submissions, AI Act Scrutiny, South Korea Guides, and More

In this week’s Pathways Picks: FDA issues draft guide on addressing new quality system framework in premarket submissions, and removes atypical warning letters; Medicare coverage determinations unleashed; EU AI Act faces reforms prospects and standards challenges; South Korea’s regulatory agency issues guides on assessing device trial safety events and on its procedures for publicly disclosing companies’ product information.

Read Article